Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Money laundering case:...

    Money laundering case: ED custody of Sterling Biotech's director extended till Feb 7

    Written by Ruby Khatun Khatun Published On 30 Jan 2018 4:45 AM  |  Updated On 30 Jan 2018 4:45 AM
    Money laundering case: ED custody of Sterling Biotechs director extended till Feb 7

    New Delhi: A Delhi court has extended till February 7 the Enforcement Directorate custody of a director of a Gujarat-based pharma firm in a money laundering case related to a Rs 5,000-crore bank fraud case.


    Additional Sessions Judge Sidharth Sharma extended the custody of Rajbhushan Omprakash Dixit, a director of Sterling Biotech, after special public prosecutor Nitesh Rana, appearing for the ED, said his further custodial interrogation was required by the agency.


    Read also: Money laundering case: Sterling Biotech’s director arrested sent to ED custody


    Rana told the court that the accused, arrested on January 25, is to be confronted with various documents and co-accused to unearth the larger conspiracy.


    This is the third arrest in the case. The agency arrested a former director of Andhra Bank, Anup Prakash Garg earlier this month, and a Delhi-based businessman Gagan Dhawan in November last year.


    While Garg is currently in judicial custody, Dhawan was granted bail on January 4. All three were arrested under the Prevention of Money Laundering Act (PMLA).


    They were named as accused in the cases by the ED and the CBI.


    The ED had registered a money laundering case after taking cognizance of a CBI FIR.


    The CBI had booked Sterling Biotech, its directors Rajbhushan, Chetan Jayantilal Sandesara, Chetan Sandesara, Nitin Jayantilal Sandesara and Vilas Joshi, chartered accountant Hemant Hathi, Garg and some unidentified persons in connection with the bank fraud case.


    It had alleged that the company had taken loans of over Rs 5,000 crore from a consortium led by Andhra Bank which had turned into non-performing assets.


    The FIR had also alleged that the total pending dues of the group companies were Rs 5,383 crore as on December 31, 2016.

    Additional Sessions Judge Sidharth SharmaAnup Prakash Gargbank fraud casecustodial interrogationcustodyDirectorEDEnforcement DirectorateextendedGagan Dhawanmoney laundering casePMLAPrevention of Money Laundering Actpublic prosecutor Nitesh RanaRajbhushan Omprakash DixitSterling Biotech
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok